Displaying drugs 901 - 925 of 1931 in total
Insulin lispro
Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas...
Approved
Matched Description: … to exert its effects within 15 minutes of subcutaneous administration, while peak levels occur 30 to 90 …
Ribavirin
Producing a broad-spectrum activity against several RNA and DNA viruses, Ribavirin is a synthetic guanosine nucleoside and antiviral agent that interferes with the synthesis of viral mRNA. It is primarily indicated for use in treating hepatitis C and viral hemorrhagic fevers. HCV is a single-stranded RNA virus that is categorized...
Approved
Matched Description: … Technivie therapy increased sustained virologic response after 12 weeks of daily therapy (SVR12) from 90% …
Temozolomide
Refractory anaplastic astrocytoma (WHO grade III) and Glioblastoma multiforme (WHO grade IV) are primary malignant brain tumours with poor prognosis and limited treatment options. Despite considerable genetic heterogeneity, these tumours often have impaired DNA repair systems, rendering them initially sensitive to alkylating agents, although they invariably develop resistance to these...
Approved
Investigational
Phenytoin
Phenytoin is classified as a hydantoin derivative and despite its narrow therapeutic index, it is one of the most commonly used anticonvulsants.[A33595,A188832,A189219] Since it's introduction about 80 years ago, phenytoin has not only been established as an effective anti-epileptic, but has also been investigated for several other indications such as...
Approved
Vet approved
Digoxin
Digoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. This drug originates from the foxglove plant, also...
Approved
Alpha-1-proteinase inhibitor
Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.
Approved
Tegaserod
Novartis' brand name Zelnorm (tegaserod) had originally received approval from the US FDA in 2002 for the treatment of irritable bowel syndrome with constipation (IBS-C).[L5918,F4229] It was, however, voluntarily withdrawn from widespread use in the US market in 2007 after concerns arose over the possibility that tegaserod could potentially cause...
Approved
Investigational
Withdrawn
Aminolevulinic acid
A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Approved
Homosalate
Homosalate is an organic compound that belongs to salicylates. It is an ester formed from salicylic acid and 3,3,5-trimethylcyclohexanol, a derivative of cyclohexanol. Salicylates prevent direct skin exposure to the sun’s harmful rays by absorbing ultraviolet (UV) light. Homosalate specifically absorbs short-wave UVB rays, which are associated with DNA damage...
Approved
Investigational
Matched Mixtures name: … Leader Kids SPF 90 ... Coppertone SPORT SPF 90 ... Walgreens 90 Sport Continuous …
Edotreotide yttrium Y-90
Investigational
Matched Synonyms: … Dotatoc yttrium Y-90 ... Yttrium y 90-edotreotide ... Y-90 dota-tyr(3)-octreotide …
Matched Name: … Edotreotide yttrium Y-90 …
Matched Name: … Edotreotide yttrium Y-90 …
AVR-RD-02
AVR-RD-02 is an investigational ex vivo lentiviral gene therapy developed by AVROBIO Inc. It consists of autologous CD34+ enriched hematopoietic stem cells (HSCs) that have been genetically modified ex vivo with a lentiviral vector (LV) to contain a ribonucleic acid (RNA) transcript that, after reverse transcription, results in codon-optimized, complementary...
Investigational
Matched Synonyms: … AVRRD-02 …
Matched Name: … AVR-RD-02 …
Matched Description: … AVR-RD-02 is being investigated in Gaucher Disease.[L45958] ... AVR-RD-02 is an investigational _ex vivo_ lentiviral gene therapy developed by AVROBIO Inc. …
Matched Name: … AVR-RD-02 …
Matched Description: … AVR-RD-02 is being investigated in Gaucher Disease.[L45958] ... AVR-RD-02 is an investigational _ex vivo_ lentiviral gene therapy developed by AVROBIO Inc. …
Yttrium Y-90 Labetuzumab
Investigational
Matched Synonyms: … Yttrium y 90 labetuzumab …
Matched Name: … Yttrium Y-90 Labetuzumab …
Matched Name: … Yttrium Y-90 Labetuzumab …
ELX-02
ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).
Investigational
Matched Name: … ELX-02 …
Matched Description: … ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult …
Matched Description: … ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult …
Yttrium Y-90 epratuzumab tetraxetan
Investigational
Matched Synonyms: … Epratuzumab tetraxetan yttrium Y-90 ... Yttrium y 90 epratuzumab tetraxetan ... Yttrium Y-90 epratuzumab tetraxetan …
Matched Name: … Yttrium Y-90 epratuzumab tetraxetan …
Matched Name: … Yttrium Y-90 epratuzumab tetraxetan …
NFS-02
NFS-02 is a recombinant adeno-associated virus serotype 2 containing human mitochondrial ND1 codon optimized gene (rAAV2-ND1).
Investigational
Matched Name: … NFS-02 …
Matched Description: … NFS-02 is a recombinant adeno-associated virus serotype 2 containing human mitochondrial ND1 codon optimized …
Matched Description: … NFS-02 is a recombinant adeno-associated virus serotype 2 containing human mitochondrial ND1 codon optimized …
BREN-02
BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1).
Investigational
Matched Name: … BREN-02 …
Matched Description: … BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1). …
Matched Description: … BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1). …
Yttrium Y-90 clivatuzumab tetraxetan
Yttrium Y-90 clivatuzumab tetraxetan is under investigation in clinical trial NCT00603863 (Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer).
Investigational
Matched Name: … Yttrium Y-90 clivatuzumab tetraxetan …
Matched Description: … Yttrium Y-90 clivatuzumab tetraxetan is under investigation in clinical trial NCT00603863 (Safety and …
Matched Description: … Yttrium Y-90 clivatuzumab tetraxetan is under investigation in clinical trial NCT00603863 (Safety and …
Tabituximab barzuxetan yttrium Y-90
A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
Matched Name: … Tabituximab barzuxetan yttrium Y-90 …
Matched Description: … A version of [tabituximab barzuxetan] radiolabeled with yttrium-90. …
Matched Description: … A version of [tabituximab barzuxetan] radiolabeled with yttrium-90. …
Ganglioside GM1
Investigational
Matched Synonyms: … Ganglioside gm1 (d18:1/18:0) ... Monosialotetrahexosylganglioside (d18:1/18:0) …
Brogidirsen
Brogidirsen is under investigation in clinical trial NCT05996003 (NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)).
Investigational
Matched Synonyms: … NS 089/NCNP 02 …
Matched Description: … Brogidirsen is under investigation in clinical trial NCT05996003 (NS-089/NCNP-02-201 in Boys With Duchenne …
Matched Description: … Brogidirsen is under investigation in clinical trial NCT05996003 (NS-089/NCNP-02-201 in Boys With Duchenne …
Efungumab
Efungumab is under investigation in clinical trial NCT00217815 (Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer).
Investigational
Matched Synonyms: … Immunoglobulin, anti-(candida heat-shock protein hsp 90) (human monoclonal hsp90mab fragment) …
Displaying drugs 901 - 925 of 1931 in total